ARKG.L
Ark Genomic Revolution Ucits ETF AccumUSD
1W: +0.3%
1M: +14.8%
YTD: +35.1%
$9.93
-0.07 (-0.74%)
Weekly Expected Move ±5.5%
$9
$9
$10
$10
$11
Overview
Chart
Holdings
Changes
Technicals
Analysis
Peers
Institutions
Dark Pool
Short Interest
Dividends
Weather
Portfolio Health Summary
IS Overall Score
41.7
★★★★★
Altman Z-Score
9.62
Safe
Weight Coverage
97%
of portfolio analyzed
Holdings Matched
29
with fundamental data
InsiderStreet Scorecard
★★★★★
41.7
Top Holdings: Score Breakdown
Risk & Quality Signals
Altman Z-Score
9.62
Safe Zone (>2.99)
Piotroski F-Score
4.3 / 9
Moderate
Beneish M-Score
-3.87
Unlikely Manipulator
Credit Score
—
Earnings Quality
53.0 / 100
Portfolio Valuation
P/E
48.28x
P/B
26.19x
P/S
13.74x
EV/EBITDA
32.22x
EV/Revenue
14.24x
P/FCF
61.90x
P/OCF
44.61x
PEG
0.76x
Earnings Yield
2.07%
FCF Yield
1.62%
OCF Yield
2.24%
Median P/E
-12.70x
Growth & Shareholder Returns
Year-over-Year Growth
Revenue
+11.5%
Net Income
+2.2%
EPS
+9.5%
FCF
-0.3%
EBITDA
+28.1%
Op. Income
—
Compound Growth Rates
Rev CAGR 3Y
+5.8%
Rev CAGR 5Y
+32.1%
EPS CAGR 3Y
+63.4%
EPS CAGR 5Y
+15.5%
FCF CAGR 3Y
+87.5%
FCF CAGR 5Y
+14.8%
EBITDA CAGR 3Y
+63.0%
EBITDA CAGR 5Y
+17.4%
Payout Ratio
5.11%
Buyback Yield
0.20%
Dividend Yield
0.02%
Total Shareholder Return
-4.49%
Earnings Stability
All Ratios & Metrics
Valuation (12)
| Metric | Value |
|---|---|
| Portfolio P/E | 48.28 |
| Portfolio P/B | 26.19 |
| Portfolio P/S | 13.74 |
| EV/EBITDA | 32.22 |
| EV/Revenue | 14.24 |
| P/FCF | 61.90 |
| P/OCF | 44.61 |
| PEG | 0.76 |
| Earnings Yield | 2.07% |
| FCF Yield | 1.62% |
| OCF Yield | 2.24% |
| Median P/E | -12.70 |
Profitability & Returns (9)
| Metric | Value |
|---|---|
| Gross Margin | 81.95% |
| Operating Margin | 36.25% |
| Net Margin | 23.90% |
| FCF Margin | 18.45% |
| ROE | 54.94% |
| ROA | 15.21% |
| ROIC | 30.27% |
| ROCE | — |
| Asset Turnover | — |
Leverage & Solvency (6)
| Metric | Value |
|---|---|
| Debt/Equity | 1.30 |
| Debt/Assets | 0.38 |
| Net Debt/EBITDA | 0.97 |
| Interest Coverage | 22.90 |
| Current Ratio | 1.61 |
| Quick Ratio | 1.27 |
Efficiency (4)
| Metric | Value |
|---|---|
| Asset Turnover | — |
| Inventory Turnover | — |
| Receivables Turnover | — |
| Payables Turnover | — |
Growth — YoY (6)
| Metric | Value |
|---|---|
| Revenue Growth | 11.51% |
| Net Income Growth | 2.24% |
| EPS Growth | 9.46% |
| FCF Growth | -0.30% |
| EBITDA Growth | 28.05% |
| Op. Income Growth | — |
Growth — CAGR (16)
| Metric | Value |
|---|---|
| Revenue CAGR 3Y | 5.83% |
| Revenue CAGR 5Y | 32.14% |
| Revenue CAGR 10Y | — |
| EPS CAGR 3Y | 63.45% |
| EPS CAGR 5Y | 15.52% |
| EPS CAGR 10Y | — |
| FCF CAGR 3Y | 87.49% |
| FCF CAGR 5Y | 14.77% |
| FCF CAGR 10Y | — |
| EBITDA CAGR 3Y | 62.98% |
| EBITDA CAGR 5Y | 17.44% |
| EBITDA CAGR 10Y | — |
| Net Income CAGR 3Y | 60.19% |
| Net Income CAGR 5Y | 15.76% |
| Op. Income CAGR 3Y | — |
| Op. Income CAGR 5Y | — |
Quality Scores (13)
| Metric | Value |
|---|---|
| IS Overall | 41.7 |
| IS Profitability | 27.6 |
| IS Balance Sheet | 46.0 |
| IS Earnings Quality | 53.0 |
| IS Growth | 53.6 |
| IS Value | 34.2 |
| IS Momentum | 56.0 |
| IS Safety | 77.9 |
| IS Quality | 47.1 |
| Altman Z-Score | 9.62 |
| Piotroski F-Score | 4.35 |
| Beneish M-Score | -3.87 |
| Credit Score | — |
Dividends & Payout (4)
| Metric | Value |
|---|---|
| Dividend Yield | 0.02% |
| Payout Ratio | 5.11% |
| Buyback Yield | 0.20% |
| Total Shareholder Return | -4.49% |
Growth Stability (4)
| Metric | Value |
|---|---|
| Revenue Stability | 0.761 |
| Earnings Stability | 0.367 |
| Earnings Persistence | 0.723 |
| Margin Stability | 0.644 |
Medians (3)
| Metric | Value |
|---|---|
| Median P/E | -12.70 |
| Median P/B | 7.09 |
| Median Dividend Yield | — |
Coverage Meta (3)
| Metric | Value |
|---|---|
| Weight Coverage % | 96.71% |
| Holdings Matched | 29 |
| Total Holdings | — |